Alpine Immune Sciences Inc buy melinda
Start price
29.02.20
/
50%
€2.78
Target price
04.11.21
€4.00
Performance (%)
302.88%
End price
05.11.21
€11.20
Summary
This prediction ended on 05.11.21 with a price of €11.20. With a performance of 302.88% the BUY prediction by melinda was a big success. melinda has 50% into this predictionAlpine Immune Sciences is a clinical-stage biotechnology company focused on developing novel therapies that modulate the immune system to treat cancer, autoimmune, and inflammatory diseases. The company's proprietary platform technology, called "Variant Ig Domain" (vIgD), enables the design and development of unique protein therapeutics that can target specific immune cells and pathways. Alpine's lead product candidate, ALPN-202, is a dual ICOS/CD28 antagonist for the treatment of autoimmune and inflammatory diseases, and the company has several other product candidates in preclinical development. Alpine Immune Sciences is listed on the NASDAQ stock exchange under the ticker symbol "ALPN".
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alpine Immune Sciences Inc | -0.826% | -0.826% | 650.000% | 383.871% |
| iShares Core DAX® | -0.268% | 5.471% | 14.271% | 19.027% |
| iShares Nasdaq 100 | 1.854% | 7.851% | 35.426% | 58.415% |
| iShares Nikkei 225® | 0.284% | 1.729% | 9.943% | 7.045% |
| iShares S&P 500 | 1.178% | 5.269% | 27.989% | 49.400% |
Comments by melinda for this prediction
In the thread Alpine Immune Sciences Inc diskutieren
In the thread Trading Alpine Immune Sciences Inc
Die von melinda gewählte maximale Laufzeit wurde überschritten
Stopped prediction by melinda for Alpine Immune Sciences Inc
Alpine Immune Sciences Inc
Start price
Target price
Perf. (%)
€4.58
13.10.18
13.10.18
€6.04
22.01.19
22.01.19
12.20%
22.01.19
22.01.19
Alpine Immune Sciences Inc
Start price
Target price
Perf. (%)
€8.48
07.12.16
07.12.16
€18.04
06.03.17
06.03.17
12.27%
06.03.17
06.03.17